344 related articles for article (PubMed ID: 29744352)
21. The problem with transferrin saturation as an indicator of iron 'sufficiency' in chronic kidney disease.
Besarab A; Drueke TB
Nephrol Dial Transplant; 2021 Jul; 36(8):1377-1383. PubMed ID: 32301986
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of Iron Status in Patients of Chronic Kidney Disease - A Study to Assess the Best Indicators Including Serum Transferrin Receptor Assay.
Venkatesan M; Saxena S; Kumar A
Indian J Nephrol; 2019; 29(4):248-253. PubMed ID: 31423058
[TBL] [Abstract][Full Text] [Related]
23. Iron deficiency and short-term adverse events in patients with decompensated heart failure.
Palau P; Llàcer P; Domínguez E; Tormo JP; Zakarne R; Mollar A; Martínez A; Miñana G; Santas E; Almenar L; Fácila L; De La Espriella R; Núñez E; Manzano L; Bayés-Genís A; Núñez J
Clin Res Cardiol; 2021 Aug; 110(8):1292-1298. PubMed ID: 33721056
[TBL] [Abstract][Full Text] [Related]
24. Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial.
Gaillard CA; Bock AH; Carrera F; Eckardt KU; Van Wyck DB; Bansal SS; Cronin M; Meier Y; Larroque S; Roger SD; Macdougall IC
PLoS One; 2016; 11(6):e0157063. PubMed ID: 27276035
[TBL] [Abstract][Full Text] [Related]
25. Iron deficiency is an independent risk factor of increased myocardial energy expenditure in chronic heart failure patients.
Lin F; Huang Y; An D; Zhan Q; Wang P; Lai W; Zeng Q; Dong S; Ren H; Xu D
Ann Palliat Med; 2021 Dec; 10(12):12061-12071. PubMed ID: 35016401
[TBL] [Abstract][Full Text] [Related]
26. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
Chen YC; Hung SC; Tarng DC
Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
[TBL] [Abstract][Full Text] [Related]
27. A 3-marker index improves the identification of iron disorders in CKD anaemia.
Mercadal L; Metzger M; Haymann JP; Thervet E; Boffa JJ; Flamant M; Vrtovsnik F; Gauci C; Froissart M; Stengel B;
PLoS One; 2014; 9(2):e84144. PubMed ID: 24586229
[TBL] [Abstract][Full Text] [Related]
28. Bone marrow macrophage iron content and sideroblast count in iron- and ESA-naïve patients with CKD-related anemia.
Capusa C; Mehedinti AM; Bârsan L; Stanciu A; Calenic A; Mircescu G
Ren Fail; 2023 Dec; 45(1):2230300. PubMed ID: 37408484
[TBL] [Abstract][Full Text] [Related]
29. Should we use ferritin in the diagnostic criteria of iron deficiency in heart failure patients?
Gentil JRS; Fabricio CG; Tanaka DM; Suen VMM; Volpe GJ; Marchini JS; Simões MV
Clin Nutr ESPEN; 2020 Oct; 39():119-123. PubMed ID: 32859304
[TBL] [Abstract][Full Text] [Related]
30. Iron status in patients with chronic heart failure.
Jankowska EA; Malyszko J; Ardehali H; Koc-Zorawska E; Banasiak W; von Haehling S; Macdougall IC; Weiss G; McMurray JJ; Anker SD; Gheorghiade M; Ponikowski P
Eur Heart J; 2013 Mar; 34(11):827-34. PubMed ID: 23178646
[TBL] [Abstract][Full Text] [Related]
31. Association between common iron store markers and hemoglobin in children with chronic kidney disease.
Atkinson MA; Pierce CB; Fadrowski JJ; Benador NM; White CT; Turman MA; Pan CG; Abraham AG; Warady BA; Furth SL
Pediatr Nephrol; 2012 Dec; 27(12):2275-83. PubMed ID: 22836305
[TBL] [Abstract][Full Text] [Related]
32. Low transferrin saturation (TSAT) and high ferritin levels are significant predictors for cerebrovascular and cardiovascular disease and death in maintenance hemodialysis patients.
Kuragano T; Joki N; Hase H; Kitamura K; Murata T; Fujimoto S; Fukatsu A; Inoue T; Itakura Y; Nakanishi T
PLoS One; 2020; 15(9):e0236277. PubMed ID: 32877424
[TBL] [Abstract][Full Text] [Related]
33. Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review.
Peyrin-Biroulet L; Williet N; Cacoub P
Am J Clin Nutr; 2015 Dec; 102(6):1585-94. PubMed ID: 26561626
[TBL] [Abstract][Full Text] [Related]
34. Towards a Common Definition for the Diagnosis of Iron Deficiency in Chronic Inflammatory Diseases.
Cacoub P; Choukroun G; Cohen-Solal A; Luporsi E; Peyrin-Biroulet L; Peoc'h K; Andrieu V; Lasocki S; Puy H; Trochu JN
Nutrients; 2022 Feb; 14(5):. PubMed ID: 35268014
[TBL] [Abstract][Full Text] [Related]
35. Iron Deficiency Anemia in Chronic Kidney Disease.
Gafter-Gvili A; Schechter A; Rozen-Zvi B
Acta Haematol; 2019; 142(1):44-50. PubMed ID: 30970355
[TBL] [Abstract][Full Text] [Related]
36. Zinc Protoporphyrin Is a Reliable Marker of Functional Iron Deficiency in Patients with Inflammatory Bowel Disease.
Leventi E; Aksan A; Nebe CT; Stein J; Farrag K
Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33670067
[TBL] [Abstract][Full Text] [Related]
37. Understanding and exploiting hepcidin as an indicator of anemia due to chronic kidney disease.
Larson DS; Coyne DW
Kidney Res Clin Pract; 2013 Mar; 32(1):11-5. PubMed ID: 26894030
[TBL] [Abstract][Full Text] [Related]
38. Anaemia, iron status, and gender predict the outcome in patients with chronic heart failure.
Kurz K; Lanser L; Seifert M; Kocher F; Pölzl G; Weiss G
ESC Heart Fail; 2020 Aug; 7(4):1880-1890. PubMed ID: 32458571
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications.
Bailie GR
Arzneimittelforschung; 2010; 60(6a):386-98. PubMed ID: 20648930
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis of Iron Deficiency in Inflammatory Bowel Disease by Transferrin Receptor-Ferritin Index.
Abitbol V; Borderie D; Polin V; Maksimovic F; Sarfati G; Esch A; Tabouret T; Dhooge M; Dreanic J; Perkins G; Coriat R; Chaussade S
Medicine (Baltimore); 2015 Jul; 94(26):e1011. PubMed ID: 26131803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
